Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serological Markers as Predictors of Anti-TNF Response in Children with Crohn's Disease.
Lisai-Goldstein Y, Focht G, Orlanski-Meyer E, Yogev D, Lev-Tzion R, Ledder O, Assa A, Navas-López VM, Baldassano RN, Otley A, Shouval DS, Griffiths AM, Turner D, Atia O. Lisai-Goldstein Y, et al. Among authors: baldassano rn. Dig Dis Sci. 2024 Nov 27. doi: 10.1007/s10620-024-08732-y. Online ahead of print. Dig Dis Sci. 2024. PMID: 39604667
Pediatric Gastrointestinal Outcomes During the Post-Acute Phase of COVID-19: Findings from RECOVER Initiative from 29 Hospitals in the US.
Zhang D, Stein R, Lu Y, Zhou T, Lei Y, Li L, Chen J, Arnold J, Becich MJ, Chrischilles EA, Chuang CH, Christakis DA, Fort D, Geary CR, Hornig M, Kaushal R, Liebovitz DM, Mosa ASM, Morizono H, Mirhaji P, Dotson JL, Pulgarin C, Sills MR, Suresh S, Williams DA, Baldassano RN, Forrest CB, Chen Y. Zhang D, et al. Among authors: baldassano rn. medRxiv [Preprint]. 2024 Jul 9:2024.05.21.24307699. doi: 10.1101/2024.05.21.24307699. medRxiv. 2024. PMID: 38826331 Free PMC article. Preprint.
Progression of Pediatric Crohn's Disease Is Associated With Anti-Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization.
Geem D, Hercules D, Pelia RS, Venkateswaran S, Griffiths A, Noe JD, Dotson JL, Snapper S, Rabizadeh S, Rosh JR, Baldassano RN, Markowitz JF, Walters TD, Ananthakrishnan A, Sharma G, Denson LA, Hyams JS, Kugathasan S. Geem D, et al. Among authors: baldassano rn. Clin Gastroenterol Hepatol. 2024 Feb;22(2):368-376.e4. doi: 10.1016/j.cgh.2023.08.042. Epub 2023 Oct 5. Clin Gastroenterol Hepatol. 2024. PMID: 37802268
Growth hormone use in pediatric inflammatory bowel disease.
Crisci M, Vellanki S, Baldassano RN, Chen Y, Liu YL, Stein R, Hatch-Stein J. Crisci M, et al. Among authors: baldassano rn. J Pediatr Endocrinol Metab. 2023 Oct 6;36(11):1012-1017. doi: 10.1515/jpem-2023-0125. Print 2023 Nov 27. J Pediatr Endocrinol Metab. 2023. PMID: 37795854
Enterobacteriaceae Growth Promotion by Intestinal Acylcarnitines, a Biomarker of Dysbiosis in Inflammatory Bowel Disease.
Lemons JMS, Conrad M, Tanes C, Chen J, Friedman ES, Roggiani M, Curry D, Chau L, Hecht AL, Harling L, Vales J, Kachelries KE, Baldassano RN, Goulian M, Bittinger K, Master SR, Liu L, Wu GD. Lemons JMS, et al. Among authors: baldassano rn. Cell Mol Gastroenterol Hepatol. 2024;17(1):131-148. doi: 10.1016/j.jcmgh.2023.09.005. Epub 2023 Sep 20. Cell Mol Gastroenterol Hepatol. 2024. PMID: 37739064 Free PMC article.
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis.
Baumdick ME, Niehrs A, Degenhardt F, Schwerk M, Hinrichs O, Jordan-Paiz A, Padoan B, Wegner LHM, Schloer S, Zecher BF, Malsy J, Joshi VR, Illig C, Schröder-Schwarz J, Möller KJ; Hamburg Intestinal Tissue Study Group; Martin MP, Yuki Y, Ozawa M, Sauter J, Schmidt AH, Perez D, Giannou AD, Carrington M, Davis RS, Schumacher U, Sauter G, Huber S, Puelles VG, Melling N, Franke A; International Inflammatory Bowel Disease Genetics Consortium; Altfeld M, Bunders MJ. Baumdick ME, et al. Gastroenterology. 2023 Oct;165(4):946-962.e13. doi: 10.1053/j.gastro.2023.06.034. Epub 2023 Jul 15. Gastroenterology. 2023. PMID: 37454979 Free PMC article.
Prior Authorizations Delay Therapy, Impact Decision-making, and Lead to Adverse Events in Inflammatory Bowel Disease: 2022 Provider Survey.
Constant BD, Albenberg L, Mitchel EB, De Zoeten EF, Clapp JT, Scott FI; PRIOR AUTHORIZATION IMPACT NETWORK STUDY GROUP. Constant BD, et al. Clin Gastroenterol Hepatol. 2024 Feb;22(2):423-426. doi: 10.1016/j.cgh.2023.06.021. Epub 2023 Jun 30. Clin Gastroenterol Hepatol. 2024. PMID: 37394025 Free article. No abstract available.
218 results